ALZA CORP
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
FDA-approved drugs
openFDA · most recent- TESTODERM TTSDec 18, 1997
- EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATEMar 29, 1996
- EFIDAC 24 CHLORPHENIRAMINE MALEATENov 18, 1994
- TESTODERMOct 12, 1993
- PROGESTASERTFeb 4, 1976
Material events
SEC Form 8-K · most recent- Item 5 · Item 7Mar 28, 2001
- Item 2Nov 14, 2000
- Item 5Nov 1, 2000
- Item 5Oct 30, 2000
- Item 5Sep 13, 2000
- Item 5Sep 6, 2000
- Item 5 · Item 7Aug 10, 2000
- Item 5 · Item 7Dec 21, 1999
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 25-NSEJul 21, 2014
- 424B3PROSPECTUS SUPPLEMENTMay 10, 2002
- 424B3PROSPECTUS SUPPLEMENTApr 12, 2002
- SC 13GANNUAL 13GFeb 7, 2002
- 424B3PROSPECTUS SUPPLEMENTNov 28, 2001
- 424B3PROSPECTUS SUPPLEMENTOct 15, 2001
- 424B3PROSPECTUS SUPPLEMENTOct 4, 2001
- 424B3PROSPECTUS SUPPLEMENTAug 31, 2001
- 424B3PROSPECTUS SUPPLEMENTAug 14, 2001
- 424B3PROSPECTUS SUPPLEMENTAug 14, 2001
- 15-12BFORM 15Jun 25, 2001
- 424B3SUPPLEMENT #4 TO PROSPECTUS DATED 11/03/01Jun 18, 2001
- DEFM14AALZA CORPORATIONMay 16, 2001
- 10-Q10QMay 14, 2001
- 10-K/AApr 18, 2001
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.